Invasive Saccharomyces Infection: A Comprehensive Review
The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Saccharomyces cerevisiae (also known as "baker's yeast" or "brewer's yeast") is mostly considered to be an occasional digestive commensal. However, since the 1990s, there have been a growing number of reports about its implication as an etiologic agent of invasive infection. A particular feature of such infections is their association with a probiotic preparation of Saccharomyces boulardii (a subtype of S. cerevisiae) for treatment various diarrheal disorders. METHODS: We collected published case reports, through May 2005, of invasive Saccharomyces infection by use of a Medline query. Epidemiological and clinical charts and therapeutic strategies were analyzed. RESULTS: We found 92 cases of Saccharomyces invasive infection. Predisposing factors were similar to those of invasive candidiasis, with intravascular catheter and antibiotic therapy being the most frequent. Blood was the most frequent site of isolation (for 72 patients). S. boulardii accounted for 51.3% of fungemias and was exclusively isolated from blood. Compared with patients infected with S. cerevisiae, patients infected with S. boulardii were more frequently immunocompetent and had a better prognosis. Saccharomyces invasive infection was clinically indistinguishable from an invasive candidiasis. Overall, S. cerevisiae clinical isolates exhibited low susceptibility to amphotericin B and azole derivatives. However, global outcome was favorable in 62% of the cases. Treatment with intravenous amphotericin B and fluconazole, in combination with central vascular catheter removal, were effective therapeutic options. CONCLUSION: Saccharomyces organisms should now be added to the growing list of emerging fungal pathogens. Special caution should be taken regarding the use of S. boulardii probiotic preparations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple cases of disseminated infection have been identified in apparent association with this probiotic, particularly in immune-suppressed individuals (39).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [39]
In the citing paper
“In a few case studies, however, S. cerevisiae has been implicated in catheter-associated infections with mixed-species biofilms in patients in intensive care units (ICUs)”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
In the citing paper
“and it is able to form a thin biofilm consisting of round, budding yeast-form cells and pseudohyphal cells in vitro (26, 50, 128, 164).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 1×
“We only considered proven infection, based on the definitions of the Invasive Fungal Infection Cooperative Group of the European Organization for Research and Treatment of Cancer–Mycosis Study Group of the National Institute of Allergy and Infectious Diseases cooperative group [19]: fungemia, isolation from normally s…”
MethodNEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Medical Mycology. The Pathogenic Fungi and Pathogenic Actinomycetes.
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-4-514_1 · Cited by 847
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 1×
“Despite this spectrum of susceptibility, a favorable outcome was observed in 63% of cases revealed in our literature search, which is a slightly higher percentage than that reported for cases of invasive candidiasis [87].”
ResultProtection from gastrointestinal diseases with the use of probiotics
Marteau, P. R., Vrese, M. D., Cellier, C. J., & Schrezenmeir, J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.430s · Cited by 596
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · cited 1×
“35[77] 76 years, F DNA fingerprinting Diabetes, heart surgery No Yes Yes Yes FLU NS Death 36 [771 72 years, F DNA fingerprinting Heart surgery No Yes Yes Yes None NS Death 37 [77] 74 years, F DNA fingerprinting Rheumatoid arthritis, corticosteroid therapy, heart surgery NS No Yes Yes FLU NS Death”
BackgroundFUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE
EUBINSTE1N, E., NOKIEGA, E. R., SIMBEEKOFF, M. S., HOLZMAN, E., & RAHAL, J. J. (1975) · Medicine · doi:10.1097/00005792-197507000-00003 · Cited by 275 · cited 1×
“1 [231 54 years, F Blood Urine Diphtheroids Valvular prosthesis No Yes Yes AmB Yes Favorable 2 [24] 38 years, M .”
BackgroundNew Spectrum of Fungal Infections in Patients with Cancer
Anaissie, E., Bodey, G. P., Kantarjian, H., Ro, J., Vartivarian, S. E., Hopfer, R., Hoy, J., & Rolston, K. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.369 · Cited by 259
Possible Role of Catheters in Saccharomyces boulardii Fungemia
Hennequin, C., Kauffmann-Lacroix, C., Jobert, A., Viard, J. P., Ricour, C., Jacquemin, J. L., & Berche, P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050003 · Cited by 253 · cited 5×
“Hand transmission has been suggested in these latter cases [5].”
BackgroundMethodInfluentialSelf-citation
Research works printed but not linked: 9
- 2001, 11, 19
- Rubinstein, 1975, Medicine, 54, 331
- Eschete, 1980, Archives of Internal Medicine, 140, 1539, 10.1001/archinte.1980.00330220085032 · doi:10.1001/archinte.1980.00330220085032
- 1997, Bulletin de la Soci t de pathologie exotique (1990), 90, 307
- Pavese, 1999, Pathologie-biologie, 47, 579
- Feld, 1982, The Journal of Rheumatology, 9, 637
- Kirsch, 1999, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 34, 229
- Zunic, 1991, Th rapie, 46, 498
- Pletincx, 1995, Journal of pediatric gastroenterology and nutrition, 21, 113, 10.1097/00005176-199507000-00022 · doi:10.1097/00005176-199507000-00022 · Paper page
Cited by
Items 101–200 of 368
Poncelet, A., Ruelle, L., Konopnicki, D., Deyi, V. Y. M., & Dauby, N. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2020.12.003 · Cited by 38
Use of soil actinomycetes for pharmaceutical, food, agricultural, and environmental purposes
Nazari, M. T., Machado, B. S., Marchezi, G., Crestani, L., Ferrari, V., Colla, L. M., & Piccin, J. S. (2022) · 3 Biotech · doi:10.1007/s13205-022-03307-y · Cited by 60
“However, in recent years, it has been reported as a cause of fungemia in immunocompromised patients who use it for medicinal purposes (Enache-Angoulvant and Hennequin 2005; Goebel et al.”
BackgroundInfluentialMayer, S., BONHAG, C. M., Jenkins, P., Cornett, B., Watts, P. J., & Scherbak, D. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005953 · Cited by 40
“It is possible that S. boulardii is more virulent than B. longum and the other probiotics analyzed, but we lack the power to establish statistical significance (21).”
Influentialde Llanos, R., Llopis, S., Molero, G., Querol, A., Gil, C., & Fernández-Espinar, M. T. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.10.025 · Cited by 37
“cerevisiae can cause clinically relevant infections in a variety of immunocompromised patients and affect different body sites (Enache-Angoulvant and Hennequin, 2005; Lolis et al., 2008; Montineri et al., 2008; Muñoz et al., 2005; Swinne et al., 2009; Williams et al., 2007); furthermore, it can sometimes even affect p…”
BackgroundInfluentialAcosta-Zaldívar, M., Andrés, M. T., Rego, A., Pereira, C. S., Fierro, J. F., & Côrte-Real, M. (2016) · Apoptosis · doi:10.1007/s10495-015-1199-9 · Cited by 37
Probiotics and zinc in acute infectious gastroenteritis in children: are they effective?
Salvatore, S., Hauser, B., Devreker, T., Vieira, M. C., Luini, C., Arrigo, S., Nespoli, L., & Vandenplas, Y. (2007) · Nutrition · doi:10.1016/j.nut.2007.03.008 · Cited by 43
Anoop, V., Rotaru, S., Shwed, P. S., Tayabali, A. F., & Arvanitakis, G. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov057 · Cited by 35
“…been often associated with administration of probiotic S. cerevisiae var. boulardii strains or certain strains of S. cerevisiae (Lherm et al. 2002; Enache-Angoulvant and Hennequin 2005; de Llanos et al. 2006b; Williams et al. 2007; Pfaller and Diekema 2010; Kliemann et al. 2011; Kelesidis and…”
BackgroundProbiotics in veterinary practice
Wynn, S. G. (2009) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.234.5.606 · Cited by 35
Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient
Landaburu, M. F., Daneri, G. L., Relloso, S., Zarlenga, L. J., Vinante, M. A., & Mujica, M. T. (2019) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2019.04.002 · Cited by 33
Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii
Khatri, I., Akhtar, A., Kaur, K., Tomar, R., Prasad, G. S., Ramya, T. N. C., & Subramanian, S. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-30 · Cited by 33
“; licensee BioMed Central L Commons Attribution License (http://creativec reproduction in any medium, provided the or Sb is a tropical strain of yeast that is thermophilic and mostly non-pathogenic to humans [5,9-12].”
BackgroundGonzales-Luna, A. J., Carlson, T. J., & Garey, K. W. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad642 · Cited by 39
Menz, G., Aldred, P., & Vriesekoop, F. (2009) · Beer in Health and Disease Prevention · doi:10.1016/b978-0-12-373891-2.00039-0 · Cited by 32
Efron, P. A., & Mazuski, J. E. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.09.014 · Cited by 36
PROBIOTIC GASTROINTESTINAL ALLERGIC REACTION CAUSED BY SACCHAROMYCES BOULARDII
Hwang, J., Kang, K. J., Kang, Y. N., & Kim, A. S. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60154-8 · Cited by 32
Alterations of Gut Mycobiota Profiles in Adenoma and Colorectal Cancer
Gao, R., Xia, K., Wu, M., Zhong, H., Sun, J., Zhu, Y., Huang, L., Wu, X., Yin, L., Yang, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.839435 · Cited by 34
Metagenomics analysis of red blood cell and fresh‐frozen plasma units
Lau, P., Cordey, S., Brito, F., Tirefort, D., Petty, T. J., Turin, L., Guichebaron, A., Docquier, M., Zdobnov, E. M., Waldvogel‐Abramowski, S., et al. (2017) · Transfusion · doi:10.1111/trf.14148 · Cited by 32
“cerevisiae.(53,54) One important limitation of HTS is its uncharacterized sensitivity.”
BackgroundEvaluation of the antifungal activities of various extracts from Pistacia atlantica Desf
Falahati, M., Sepahvand, A., Mahmoudvand, H., Baharvand, P., Jabbarnia, S., Ghojoghi, A., & Yarahmadi, M. (2015) · Current Medical Mycology · doi:10.18869/acadpub.cmm.1.3.25 · Cited by 35
“Therefore, this organism should be included in the growing list of emerging fungal pathogens [4].”
BackgroundBugs or drugs: Are probiotics safe for use in the critically ill?
Urben, L. M., Wiedmar, J., Boettcher, E., Cavallazzi, R., Martindale, R. G., & McClave, S. A. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0388-y · Cited by 29
Plant Organic Acids as Natural Inhibitors of Foodborne Pathogens
Karpiński, T. M. M., & Ożarowski, M. (2024) · Applied Sciences · doi:10.3390/app14146340 · Cited by 34
Pathogenic Potential of Saccharomyces Strains Isolated from Dietary Supplements
Llopis, S., Hernández‐Haro, C., Monteoliva, L., Querol, A., Molina, M., & Fernández-Espinar, M. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098094 · Cited by 32
“cerevisiae as harmless has changed due to an increase in the number of infections caused by this yeast [6,59,60].”
BackgroundPopiel, K. Y., Wong, P. Y. N., Lee, M. J., Langelier, M. J., Sheppard, D. C., & Vinh, D. C. (2015) · Transplant Infectious Disease · doi:10.1111/tid.12384 · Cited by 32
“Studies using broth microdilution, summarized in an analysis by Enache-Angoulvant and Hennequin (24), reveal relatively low in vitro susceptibility to amphotericin B (MIC50: 0.”
MethodInfluentialChang, H.-W., Nam, Y., Sung, Y., Kim, K., Roh, S. W., Yoon, J., An, K., & Bae, J. (2007) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2007.08.013 · Cited by 28
Money, N. P. (2024) · Fungal Biology · doi:10.1016/j.funbio.2024.01.005 · Cited by 34
Clostridium difficile Infection
Knight, C. L., & Surawicz, C. M. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.02.003 · Cited by 34
“Fungemia from S boulardii has been reported in patients with central venous catheters, and it should be avoided in critically ill and immunocompromised patients.(66)”
BackgroundBugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children
Barnes, D. M., & Yeh, A. M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615610081 · Cited by 37
Willaert, R., Kayacan, Y., & Devreese, B. V. (2021) · Pathogens · doi:10.3390/pathogens10111397 · Cited by 27
The management of Clostridium difficile infection
Williams, O. M., & Spencer, R. C. (2009) · British Medical Bulletin · doi:10.1093/bmb/ldp021 · Cited by 30
Rare Invasive Fungal Infections: Epidemiology, Diagnosis and Management
Meletiadis, J., & Roilides, E. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0155-9 · Cited by 29
“boulardii, which is used as probiotic to avoid various types of diarrhea [34].”
BackgroundExperience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
Sulik‐Tyszka, B., Snarski, E., Niedźwiedzka, M., Augustyniak, M., Myhre, T. N., Kacprzyk, A., Swoboda‐Kopeć, E., Roszkowska, M., Dwilewicz‐Trojaczek, J., Wiktor-Jędrzejczak, W., et al. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9332-4 · Cited by 27
“important while administering probiotics containing yeasts to the immunocompromised patients [34].”
Infections caused by non- Candida , non- Cryptococcus yeasts
Pfaller, M. A., Diekema, D. J., & Merz, W. G. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5680-5.00010-4 · Cited by 32
Heil, E. L., Harris, A. D., Brown, C. H., Seung, H., Thom, K. A., von Rosenvinge, E. C., Sorongon, S., Pineles, L. L., Goodman, K. E., & Leekha, S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab417 · Cited by 29
The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease
Meng, L., Liu, C., Li, Y., Chen, G., Xiong, M., Yu, T., Pan, L., Zhang, X., Zhou, L., Guo, T., et al. (2023) · Science Advances · doi:10.1126/sciadv.adj1092 · Cited by 25
Clostridium difficile infection: clinical spectrum and approach to management
Vaishnavi, C. V. (2011) · Indian Journal of Gastroenterology · doi:10.1007/s12664-011-0148-y · Cited by 24
Drunk Without Drinking: A Case of Auto-Brewery Syndrome
Akhavan, B. J., Ostrosky-Zeichner, L. L., & Thomas, E. J. (2019) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000208 · Cited by 24
“11 Some of these cases also had resolution with surgical intervention, such as gastrectomy.”
BackgroundMaxwell, P. H. (2020) · Mobile DNA · doi:10.1186/s13100-020-00215-x · Cited by 23
Quantitative agar-invasion assay
Zupan, J., & Raspor, P. (2008) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2008.02.009 · Cited by 23
“Saccharomyces boulardii) (Enache-Angoulvant and Hennequin, 2005) necessitating the development of molecular markers for distinguishing S.”
BackgroundClinical Saccharomyces cerevisiae isolates cannot cross the epithelial barrier in vitro
Pérez‐Torrado, R., Llopis, S., Jespersen, L., Fernández-Espinar, M. T., & Querol, A. (2012) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2012.04.012 · Cited by 24
Savini, V., Catavitello, C., Manna, A., Talia, M., Febbo, F., Balbinot, A., D’Antonio, F., Bonaventura, G. D., Celentano, C., Liberati, M., et al. (2008) · Mycopathologia · doi:10.1007/s11046-008-9119-y · Cited by 22
Expression variability of co-regulated genes differentiates Saccharomyces cerevisiae strains
Carreto, L. C., Eiriz, M. F., Domingues, I., Schuller, D. E., Moura, G. R., & Santos, M. A. S. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-201 · Cited by 32
“Recently, wild type strains have been isolated from infections of immunocompromised individuals [6], raising concerns about their virulence potential.”
BackgroundGlucose, Cyc8p and Tup1p regulate biofilm formation and dispersal in wild Saccharomyces cerevisiae
Nguyen, P. V., Plocek, V., Váchová, L., & Palková, Z. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-0118-1 · Cited by 25
“cerevisiae infection have been reported in these patients.(1) An increase in glucose level has been detected in blood and other body niches such as urine, intestinal fluid, mucus, 0.”
BackgroundWilliams, J. S., Mufti, G. J., Powell, S. N., Salisbury, J. R., & Higgins, E. M. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02375.x · Cited by 22
Diezmann, S., & Dietrich, F. S. (2011) · Genetics · doi:10.1534/genetics.111.128256 · Cited by 26
“…S. cerevisiae can cause a wide spectrum of diseases ranging from superficial cutaneous infections and vaginitis to life-threatening systemic infections of the blood stream and vital organs in immunocompetent and immunocompromised individuals (Enache-Angoulvant and Hennequin 2005; McCusker 2006).”
BackgroundEpidemiology of Saccharomyces fungemia: A systematic review
Vinayagamoorthy, K., Pentapati, K. C., & Prakash, H. (2023) · Medical Mycology · doi:10.1093/mmy/myad014 · Cited by 30
Saccharomyces cerevisiae: A Unicellular Model Genetic Organism of Enduring Importance
Hanson, P. K. (2018) · Current Protocols Essential Laboratory Techniques · doi:10.1002/cpet.21 · Cited by 31
Imre, A., Rácz, H. V., Antunovics, Z., Rádai, Z., Kovács, R., Lopandić, K., Pócsi, I., & Pfliegler, W. P. (2019) · Microbiological Research · doi:10.1016/j.micres.2019.126298 · Cited by 25
Probiotic yeastSaccharomyces boulardii(nom. nud.) modulates adhesive properties ofCandida glabrata
Tomičić, Z., Zupan, J., Matos, T., & Raspor, P. (2016) · Medical Mycology · doi:10.1093/mmy/myw026 · Cited by 24
Martins, D., Nguyen, D. M., & English, A. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-45070-w · Cited by 22
Invasive growth of Saccharomyces cerevisiae depends on environmental triggers: a quantitative model
Zupan, J., & Raspor, P. (2010) · Yeast · doi:10.1002/yea.1746 · Cited by 24
“cerevisiae, and the environmental factors that trigger invasive growth, are still not well understood (Enache-Angoulvant and Hennequin, 2005; McCusker et al., 1994).”
BackgroundInfluentialTyler, A. R., Okoh, O. A., Lawrence, C. L., Jones, V. C., Moffatt, C., & Smith, R. B. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.031 · Cited by 24
Tome, M., Zupan, J., Tomičić, Z., Matos, T., & Raspor, P. (2018) · PeerJ · doi:10.7717/peerj.4999 · Cited by 21
Krishnan, R., Pant, T., Sankaranarayan, S., Stenberg, J., Jain, R. D., & Dandekar, P. P. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.08.016 · Cited by 20
Preventing Clostridium Difficile Infection in the Intensive Care Unit
Zilberberg, M. D., & Shorr, A. F. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.10.006 · Cited by 18
Infección por Saccharomyces cerevisiae
Goebel, C. S., Oliveira, F. D. M., & Severo, L. C. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.03.001 · Cited by 18
Abdel‐Sater, M. A., Moubasher, A. H., & Soliman, Z. S. M. (2016) · Mycoses · doi:10.1111/myc.12520 · Cited by 18
FUNGEMIA POR SACCHAROMYCES CEREVISIAE EM PACIENTE PEDIÁTRICO APÓS TRATAMENTO COM PROBIÓTICO
Romanio, M. R., Coraine, L. A., Maielo, V. P., Abramczyk, M. L., de Souza, R. R., & Oliveira, N. F. (2017) · Revista Paulista de Pediatria · doi:10.1590/1984-0462/;2017;35;3;00014 · Cited by 18
Yáñez, A., Murciano, C., Llopis, S., Fernández-Espinar, M. T., Gil, M. L., & Gozalbo, D. (2009) · The Open Mycology Journal · doi:10.2174/1874437000903010037 · Cited by 17
“cerevisiae is responsible for superficial diseases, that are not life-threatening, although in severely immunocompromised individuals serious systemic infection may occur [4-7].”
BackgroundZupan, J., Mavri, J., & Raspor, P. (2009) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2009.09.003 · Cited by 23
“cerevisiae, have increased in the last years, ranging this species with the group of emergent pathogens (Casalone et al., 2005; Enache-Angoulvant and Hennequin, 2005; Malgoire et al., 2005).”
BackgroundLlopis, S., Querol, A., Heyken, A., Hube, B., Jespersen, L., Fernández-Espinar, M. T., & Pérez‐Torrado, R. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-419 · Cited by 19
“; licensee BioMed Central L Commons Attribution License (http://creativec reproduction in any medium, provided the or healthy patients to systemic infections of the bloodstream and vital organs in immunocompromised and critically ill patients [1-3].”
Baker’s Yeast Clinical Isolates Provide a Model for How Pathogenic Yeasts Adapt to Stress
Raghavan, V., Aquadro, C. F., & Alani, E. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.08.002 · Cited by 20
“cerevisiae infections in immunosuppressed individuals [5, 21].”
BackgroundInfluentialComparative genomics of infective Saccharomyces cerevisiae strains reveals their food origin
Morard, M., Pérez‐Través, L., Perpiñá, C., Lairón‐Peris, M., Collado, M. C., Pérez‐Torrado, R., & Querol, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-36857-z · Cited by 23
Prebiotics, Probiotics, and Synbiotics
Chen, L. A., & Sears, C. L. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00003-5 · Cited by 23
Phadke, S. S., Maclean, C. J., Zhao, S. Y., Mueller, E. A., Michelotti, L. A., Norman, K. L., Kumar, A., & James, T. Y. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300245 · Cited by 20
Stojković, D. S., Kostić, M., Smiljkovic, M. S., Aleksić, M., Vasiljevic, P. J., Nikolić, M., & Sokóvić, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180309103645 · Cited by 17
Uncommon Yeasts and Molds Causing Human Disease
Shoff, C. J., & Perfect, J. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.21023-6 · Cited by 18
Manzanares, W., Langlois, P. L., & Wischmeyer, P. E. (2017) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607117700572 · Cited by 15
Probiotics and prebiotics in pediatric diarrheal disorders
Vandenplas, Y., Greef, E. D., Hauser, B., Devreker, T., & Veereman-Wauters, G. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.771632 · Cited by 16
“A central venous catheter is the main risk factor [102].”
BackgroundMicro- and Nanoscale Approaches in Antifungal Drug Discovery
Willaert, R. (2018) · Fermentation · doi:10.3390/fermentation4020043 · Cited by 18
“Since the 1990s, there have been a growing number of reports about Saccharomyces cerevisiae invasive infections and novel strains continue to be identified [24,30,31].”
BackgroundHabitat Predicts Levels of Genetic Admixture in Saccharomyces cerevisiae
Tilakaratna, V., & Bensasson, D. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.041806 · Cited by 14
“Fruit, fl owers, and insects represent habitats that are transient for yeast (Goddard and Greig 2015; Knight and Goddard 2016) and S. cerevisiae also occurs in humans only transiently (Enache-Angoulvant and Hennequin 2005).”
Barig, S., Alisch, R., Nieland, S., Wuttke, A., Gräser, Y., Huddar, M., Schnitzlein, K., & Stahmann, K. ‐. (2011) · Engineering in Life Sciences · doi:10.1002/elsc.201000219 · Cited by 15
Probiotics in Inflammatory Bowel Disease: Yet Another Mechanism of Action?
Fiocchi, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.051 · Cited by 16
Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit
Clemons, K. V., Salonen, J. H., Issakainen, J., NIKOSKELAINEN, J., McCullough, M. J., Jorge, J., & Stevens, D. A. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.06.010 · Cited by 14
“…S. cerevisiae as a significant cause of vaginitis and demonstrated the increased incidence of its recovery from clinical specimens sent for culture (Enache-Angoulvant and Hennequin, 2005; Eng et al., 1984; Herbrecht and Nivoix, 2005; Munoz et al., 2005; Murphy and Kavanagh, 1999; Nyirjesy et al.,…”
BackgroundLewis, P. O., Lundberg, T. S., Tharp, J. L., & Runnels, C. W. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017694050 · Cited by 15
“Although our formulary product in this study was Lactobacillus/ Bifidobacterium, there have been studies published regarding the development of invasive disease with the use of Saccharomyces boulardii, specifically in critically ill patients with severe pancreatitis.(16,17) The CDC specifically cautions against the us…”
ResultPiechno, S., Séguin, P., & Gangneux, J. (2007) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03022650 · Cited by 14
Guo, R., Chen, Z., Chen, N., & Chen, Y. (2010) · Laboratory Medicine · doi:10.1309/lmmc0wvzxd13pujg · Cited by 17
An Updated Review of Clostridium difficile Treatment in Pediatrics
Campbell, C. T., Poisson, M. O., & Hand, E. (2019) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-24.2.90 · Cited by 16
Stool Transplants: Ready for Prime Time?
Weissman, J., & Coyle, W. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0263-7 · Cited by 14
“Saccharomyces boulardii has been studied as an adjunct therapy with high dose vancomycin to decrease CDI recurrence [13].”
BackgroundGengaimuthu, K. (2018) · Cureus · doi:10.7759/cureus.2691 · Cited by 14
Safety and the probiotic potential of Bifidobacterium animalis CP‐9
Tsai, H., Wang, Y., Liao, C., Su, C., Huang, C., Chiu, M., & Yeh, Y. (2022) · Journal of Food Science · doi:10.1111/1750-3841.16129 · Cited by 14
Pérez‐Torrado, R., Llopis, S., Perrone, B., Gómez‐Pastor, R., Hube, B., & Querol, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122382 · Cited by 16
“cerevisiae, which is now considered to be an emerging opportunistic pathogen [6–9].”
BackgroundPérez‐Cantero, A., Thomson, P., Paredes, K., Guarro, J., & Capilla, J. (2019) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2018.04.004 · Cited by 13
Clostridium difficile: new therapeutic options
Balagopal, A., & Sears, C. L. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.05.007 · Cited by 14
Clostridium difficile: biological therapies
Martin, J. S. H., Mawer, D. P. C., & Wilcox, M. H. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000433319.82618.8f · Cited by 13
“boulardii probiotic preparation, and another 8% had been in close contact with a probiotic recipient [27].”
Rare Yeast Infections: Risk Factors, Clinical Manifestations, Treatment, and Special Considerations
Byrne, D. D., & Reboli, A. C. (2017) · Current Clinical Microbiology Reports · doi:10.1007/s40588-017-0073-7 · Cited by 14
Commission For Hospital Hygiene And Infection Prevention (KRINKO) (2022) · GMS. Hygiene and infection control · doi:10.3205/dgkh000410 · Cited by 18
“…analyses of various patient populations, individual case reports and case series suggest that probiotic microorganisms very rarely cause systemic (bloodstream) infections [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202].”
Zingmark, L. B., Widbom, L., Hultdin, J., Eriksson, C., & Karling, P. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07630-5 · Cited by 14
“However, because Saccharomyces cerevisiae originates from food and its occurrence in the gastrointestinal tract is transient, it has been debated if the yeast should be considered to belong to the commensal flora of the gut or not [29, 30].”
BackgroundGut yeast communities inLarus michahellisfrom various breeding colonies
Al-Yasiri, M. H., Normand, A., Piarroux, R., Ranque, S., & Mauffrey, J.-F. (2016) · Medical Mycology · doi:10.1093/mmy/myw088 · Cited by 14
Pouch, S. M., & Friedman‐Moraco, R. (2018) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.05.001 · Cited by 12
Probiotics to prevent necrotizing enterocolitis: Too cheap and easy?
Taylor, R. S. (2014) · Paediatrics & Child Health · doi:10.1093/pch/19.7.351 · Cited by 12
“Probiotics are not all equal: One of the most commonly used probiotics is the baker’s yeast Saccharomyces boulardii (Florastor, Biocodex, USA), which does not prevent NEC but has been reported to cause fungal sepsis (15,16) in immunocompromised patients.”
BackgroundRare Yeasts in Latin America: Uncommon Yet Meaningful
Gil, Ó., Hernández-Pabón, J. C., Tabares, B., Lugo-Sánchez, C., & Firacative, C. (2023) · Journal of Fungi · doi:10.3390/jof9070747 · Cited by 15
Yan, Z., Fu, Y., Tan, X., Xu, L., Ling, J., Liu, X., Miao, C., Liu, L., Cui, Y., Li, H., et al. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03506-y · Cited by 11
“As an opportunistic pathogenic fungus, S. cerevisiae has been shown to cause fungemia [5], fungal pneumonia [6], and vulvovaginal candidiasis (VVC) [7] in humans under certain conditions.”
BackgroundResultA Repertoire of the Less Common Clinical Yeasts
Menu, E., Filori, Q., Dufour, J.-C., Ranque, S., & L’Ollivier, C. (2023) · Journal of Fungi · doi:10.3390/jof9111099 · Cited by 15
Qiu, J., Zhao, N., Cheng, Y., Qiao-xia, C., Xu, Y., Lu, Y., Gao, J., Lei, W., Yan, C., Ling, Z., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1317809 · Cited by 11
“These genera have been previously implicated in various disease contexts (26 – 28), supporting the notion that they might play a signi fi cant role in the interplay between hypertension and CKD. Conversely, the reduced abundance of Candida and potentially other fungal genera in individuals with both…”
BackgroundSaccharomyces cerevisiaeLaryngitis and Oral Lesions in a Patient with Laryngeal Carcinoma
Algazaq, J. N., Akrami, K., Martínez, F. D., McCutchan, A., & Bharti, A. (2017) · Case Reports in Infectious Diseases · doi:10.1155/2017/2941527 · Cited by 11
Jainlabdin, M. H., Batra, A., Sánchez-Paredes, E., Hernández, F. H., Fu, G., & Tovar-Torres, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51198-6 · Cited by 13
Lawrence, C. L., Okoh, O. A., Vishwapathi, V., McKenna, S. T., Critchley, M. E., & Smith, R. B. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104070 · Cited by 11
Du, M., Liu, F., Luan, X., & Li, G. (2021) · Biomedical Optics Express · doi:10.1364/boe.448729 · Cited by 10
Li, G., Du, M., Yang, J. R., Luan, X., Liu, L., & Liu, F. (2021) · IEEE Sensors Journal · doi:10.1109/jsen.2021.3072387 · Cited by 10
Saccharomyces cerevisiae fungemia due to an unexpected source in the pediatric intensive care unit
Gün, E., Özdemir, H., Çelik, D. B., Botan, E., & Kendirli, T. (2022) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2020.1668 · Cited by 10
Queiroz, P. A., Godoy, J. S. R., Mendonca, P., Pedroso, R. B., Svidzinski, T. I. E., & Negri, M. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000122 · Cited by 13
“It is generally associated with yeasts of the genus Candida, with high mortality rates (Enache-Angoulvant & Hennequin, 2005; Eren et al., 2014; Silva et al., 2011a).”
Backgroundde Llanos, R., Hernández‐Haro, C., Barrio, E., Querol, A., Fernández-Espinar, M. T., & Molina, M. (2010) · Yeast · doi:10.1002/yea.1799 · Cited by 12
Metadata
- Authors
- Enache-Angoulvant, A., & Hennequin, C.
- Affiliations
- Hôpital Tenon (FR)
- Corresponding author
- Hennequin, C.
- ORCID
- Hennequin, C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 41
- Issue
- 11
- Pages
- 1559-1568
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2168407031
- Cited by
- 369
- References
- 88
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 10 · 2023: 17 · 2022: 14 · 2021: 17 · 2020: 24 · 2019: 19 · 2018: 23 · 2017: 34 · 2016: 19 · 2015: 23 · 2014: 14 · 2013: 23 · 2012: 18
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- Saccharomyces cerevisiae, Saccharomyces boulardii, invasive candidiasis, fungemia, emerging fungal pathogens, amphotericin B susceptibility, fluconazole, central venous catheters, antibiotic therapy, immunocompetent patient
- MeSH terms
- Female, Humans, Male, Mycoses, Risk Factors, Saccharomyces
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.